Return to search

Will Mortality Rate of HIV-Infected Patients Decrease After Starting Antiretroviral Therapy (ART)?

Indiana University-Purdue University Indianapolis (IUPUI) / Background: Many authors have indicated that HIV-infected patients mortality risk is higher immediately following the start of Antiretroviral Therapy. However, mortality rate of HIV-infected patients is expected to decrease after starting Antiretroviral Therapy (ART) potentially complicating accurate statistical estimation of patient survival and, more generally, effective monitoring of the evolution of the worldwide epidemic.
Method: In this thesis, we determine if mortality of HIV-patients increases or decreases after the initiation of ART therapy using flexible survival modelling techniques. To achieve this objective, this study uses semi-parametric statistical models for fitting and estimating survival time using different covariates. A combination of the Weibull distribution with splines is compared to the usual Weibull, exponential, and gamma distribution parametric models, and the Cox semi-parametric model. The objective of this study is to compare these models to find the best fitting model so that it can then be used to improve modeling of the survival time and explore the pattern of change in mortality rates for a cohort of HIV-infected patients recruited in a care and treatment program in Uganda.
Results: The analysis shows that flexible survival Weibull models are better than usualoff-parametric and semi-parametric model fitting according to the AIC criterion.
Conclusion: The mortality of HIV-patients is high right after the initiation of ART therapy and decreases rapidly subsequently.

Identiferoai:union.ndltd.org:IUPUI/oai:scholarworks.iupui.edu:1805/23574
Date07 1900
CreatorsBahakeem, Shaher
ContributorsYiannoutsos, Constantin, Bakoyannis, Giorgos, Fadel, William
Source SetsIndiana University-Purdue University Indianapolis
LanguageEnglish
Detected LanguageEnglish
TypeThesis
RightsAttribution-NoDerivatives 4.0 International, http://creativecommons.org/licenses/by-nd/4.0/

Page generated in 0.002 seconds